Fig. 3From: Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality registerProportion of patients achieving LUNDEX-corrected HAQ response by previous bDMARD exposure. p < 0.002 for bionaïve patients vs patients treated with 1 and with ≥ 2 previous bDMARDs. Bars are 95% CIBack to article page